Halogenated benzimidazole carboxamides target integrin α 4β1 on T-cell and B-cell lymphomas

Richard D. Carpenter, Arutselvan Natarajan, Edmond Y Lau, Mirela Andrei, Danielle M. Solano, Felice C Lightstone, Sally J. DeNardo, Kit Lam, Mark J. Kurth

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Integrin α4β1 is an attractive but poorly understood target for selective diagnosis and treatment of T-cell and B-cell lymphomas. This report focuses on the rapid microwave preparation, structure-activity relationships, and biological evaluation of medicinally pertinent benzimidazole heterocycles as integrin α4β 1 antagonists. We documented tumor uptake of derivatives labeled with 125I in xenograft murine models of B-cell lymphoma. Molecular homology models of integrin α4β1 predicted that docked halobenzimidazole carboxamides have the halogen atom in a suitable orientation for halogen-hydrogen bonding. The high-affinity halogenated ligands identified offer attractive tools for medicinal and biological use, including fluoro and iodo derivatives with potential radiodiagnostic (18F) or radiotherapeutic (131I) applications, or chloro and bromo analogues that could provide structural insights into integrin-ligand interactions through photoaffinity, cross-linking/mass spectroscopy, and X-ray crystallographic studies.

Original languageEnglish (US)
Pages (from-to)5448-5456
Number of pages9
JournalCancer Research
Volume70
Issue number13
DOIs
StatePublished - Jul 1 2010

Fingerprint

B-Cell Lymphoma
Integrins
T-Lymphocytes
Halogens
Ligands
Molecular Models
Hydrogen Bonding
Structure-Activity Relationship
Microwaves
Heterografts
Mass Spectrometry
X-Rays
benzimidazole
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Halogenated benzimidazole carboxamides target integrin α 4β1 on T-cell and B-cell lymphomas. / Carpenter, Richard D.; Natarajan, Arutselvan; Lau, Edmond Y; Andrei, Mirela; Solano, Danielle M.; Lightstone, Felice C; DeNardo, Sally J.; Lam, Kit; Kurth, Mark J.

In: Cancer Research, Vol. 70, No. 13, 01.07.2010, p. 5448-5456.

Research output: Contribution to journalArticle

Carpenter, Richard D. ; Natarajan, Arutselvan ; Lau, Edmond Y ; Andrei, Mirela ; Solano, Danielle M. ; Lightstone, Felice C ; DeNardo, Sally J. ; Lam, Kit ; Kurth, Mark J. / Halogenated benzimidazole carboxamides target integrin α 4β1 on T-cell and B-cell lymphomas. In: Cancer Research. 2010 ; Vol. 70, No. 13. pp. 5448-5456.
@article{293e88eb046743fd8ce826bda172b989,
title = "Halogenated benzimidazole carboxamides target integrin α 4β1 on T-cell and B-cell lymphomas",
abstract = "Integrin α4β1 is an attractive but poorly understood target for selective diagnosis and treatment of T-cell and B-cell lymphomas. This report focuses on the rapid microwave preparation, structure-activity relationships, and biological evaluation of medicinally pertinent benzimidazole heterocycles as integrin α4β 1 antagonists. We documented tumor uptake of derivatives labeled with 125I in xenograft murine models of B-cell lymphoma. Molecular homology models of integrin α4β1 predicted that docked halobenzimidazole carboxamides have the halogen atom in a suitable orientation for halogen-hydrogen bonding. The high-affinity halogenated ligands identified offer attractive tools for medicinal and biological use, including fluoro and iodo derivatives with potential radiodiagnostic (18F) or radiotherapeutic (131I) applications, or chloro and bromo analogues that could provide structural insights into integrin-ligand interactions through photoaffinity, cross-linking/mass spectroscopy, and X-ray crystallographic studies.",
author = "Carpenter, {Richard D.} and Arutselvan Natarajan and Lau, {Edmond Y} and Mirela Andrei and Solano, {Danielle M.} and Lightstone, {Felice C} and DeNardo, {Sally J.} and Kit Lam and Kurth, {Mark J.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-09-3736",
language = "English (US)",
volume = "70",
pages = "5448--5456",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Halogenated benzimidazole carboxamides target integrin α 4β1 on T-cell and B-cell lymphomas

AU - Carpenter, Richard D.

AU - Natarajan, Arutselvan

AU - Lau, Edmond Y

AU - Andrei, Mirela

AU - Solano, Danielle M.

AU - Lightstone, Felice C

AU - DeNardo, Sally J.

AU - Lam, Kit

AU - Kurth, Mark J.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Integrin α4β1 is an attractive but poorly understood target for selective diagnosis and treatment of T-cell and B-cell lymphomas. This report focuses on the rapid microwave preparation, structure-activity relationships, and biological evaluation of medicinally pertinent benzimidazole heterocycles as integrin α4β 1 antagonists. We documented tumor uptake of derivatives labeled with 125I in xenograft murine models of B-cell lymphoma. Molecular homology models of integrin α4β1 predicted that docked halobenzimidazole carboxamides have the halogen atom in a suitable orientation for halogen-hydrogen bonding. The high-affinity halogenated ligands identified offer attractive tools for medicinal and biological use, including fluoro and iodo derivatives with potential radiodiagnostic (18F) or radiotherapeutic (131I) applications, or chloro and bromo analogues that could provide structural insights into integrin-ligand interactions through photoaffinity, cross-linking/mass spectroscopy, and X-ray crystallographic studies.

AB - Integrin α4β1 is an attractive but poorly understood target for selective diagnosis and treatment of T-cell and B-cell lymphomas. This report focuses on the rapid microwave preparation, structure-activity relationships, and biological evaluation of medicinally pertinent benzimidazole heterocycles as integrin α4β 1 antagonists. We documented tumor uptake of derivatives labeled with 125I in xenograft murine models of B-cell lymphoma. Molecular homology models of integrin α4β1 predicted that docked halobenzimidazole carboxamides have the halogen atom in a suitable orientation for halogen-hydrogen bonding. The high-affinity halogenated ligands identified offer attractive tools for medicinal and biological use, including fluoro and iodo derivatives with potential radiodiagnostic (18F) or radiotherapeutic (131I) applications, or chloro and bromo analogues that could provide structural insights into integrin-ligand interactions through photoaffinity, cross-linking/mass spectroscopy, and X-ray crystallographic studies.

UR - http://www.scopus.com/inward/record.url?scp=77954374488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954374488&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-3736

DO - 10.1158/0008-5472.CAN-09-3736

M3 - Article

C2 - 20530664

AN - SCOPUS:77954374488

VL - 70

SP - 5448

EP - 5456

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 13

ER -